Skip to main content
. 2017 Sep 28;102(12):4568–4577. doi: 10.1210/jc.2017-01411

Table 3.

Bone Density and Body Composition at Baseline and 12 Months

Baseline
12 mo
Change
P1 P2 P3a P2 P3a P2 P3
DXA
 Age, y 19 14 10 15 11
 Height SDS −3.8 −2.9 −2.9 −3.0 −2.5 −1 +0.4
 Whole body minus head
  BMD, g/cm2 0.764 0.652 0.569 0.716 0.646 9.9% 13.6%
  z Score −2.9 −3.6 −2.5 −3.2 −1.8 +0.4 +0.7
  HA z score −0.5 −2.5 −0.7 −2.2 −0.1 +0.3 +0.6
 Lumbar spine
  BMD, g/cm2 0.749 0.504 0.497 0.531 0.561 5.4% 12.9%
  z Score −2.7 −3.2 −1.6 −3.9 −1.0 −0.7 +0.6
  HA z score −1 −1.3 −0.1 −1.9 0.3 −0.6 +0.4
 Total hip
  BMD, g/cm2 0.726 0.567 0.593 0.600 0.629 5.9% 6.1%
  z Score −1.8 −3.8 −2.1 −3.5 −2.0 +0.3 +0.1
  HA z score −0.03 −1.6 −0.5 −2.0 −0.4 −0.4 +0.1
 Forearm
  BMD, g/cm2 0.627 0.499 0.448 0.538 0.486 7.6% 8.5%
  z Score −1.1 −2.8 −1.9 −2.8 −1.3 0 +0.6
  HA z score 0 −1.7 −0.5 −1.8 0 −0.1 +0.5
 Total lean body mass, g 23092 27286 15274 32964 18961 20.8% 24.1%
 Total fat mass, g 17809 27380 6543 26969 7390 −1.5% 12.9%
 Total body fat % 42.3 49.2 29 44.2 27.1 −5 −1.9
Bone markers
 C-telopeptides, ng/mL 726 1974 1744 1855 2262 −6% 29%
 Osteocalcin, ng/mL 28 101 86 138 123 38% 43%

Abbreviation: HA, height-adjusted.

a

Patient treated with rhIGF-1.